Summary. The use of polyethylene glycol 6000 to separate free and antibody-bound ligand has been applied to the radioimmmloassay of glueagon. Equalization of protein content in all tubes before precipitation of the glucagon-antibody complex was required. Time between addition of the polymer and centrifugation had no detecbable effect. Degradation of 181I-glucagon during in. cubation was best prevented by a combination of benzamidine (5 mM) and Trasy]ol| (500 KIE/tube). Sensitivity of the assay permitted discrimination of buffer or plasma samples (100 ~1) whose glucagon contents differed from 25 pg/ml, under 100 pg/ml, and 35 pg/ml, under 200 pg/ml. Reproducibility was 9.5 ~o (coefficient of variation) for plasmas with glucagon concentrations ranging from 100 to 300 pg/ml. Recovery of exogenous glueagon added to plasma was satisfactory. Measurement of glucagon was possible in fasting plasma samples diluted up to 1/8. The separation method described appears to be easy and reliable, especially when large numbers of samples are routinely handled.
ments have been introduced (see ref. 21 for a review).
Besides utilization of antisera specific for pancreatic glueagon and adequate prevention of labelled glucagon degradation during incubation, most of the refinements of the technique are dealing with the separation of free and antibody-bound hormone.
Three major groups of methods are available. Separation may be carried out by paper chromatography [3, 19, 27, 34] . The glucagon-antibody complex may be precipitated by Na2SO a [14] , a second antibody [15, 29] , or ethanol [10, 16] . Finally, fl'ee glucagon may be selectively adsorbed by an ionic exchange resin [38] , cellulose powder [26] or dextran-coated charcoal [2, 20] .
Recently, the use of polyethylene glycol 6000 (PEG) to precipitate antibody-bound ligand from the free compound was reported by Desbuquois and Aurbach [8] . So far, this separation technique has been successfully used in radioimmunoassays of insulin, growth hormone, parathyroid hormone [8] , arginine-vasopressin [8, 13] , cyclic AMP [8, 28] , angietensin I and digoxin [6] .
The purpose of this report is to describe the application of this new separation method to glueagon immunoassay.
Materials

Buffer8
A sodium phosphate buffer (0.04 M, pH 7.4) with 0.1 g bovine serum albumin/100 ml and 0.02 g Merthiolate| ml (buffer GA) was used for the dilution of labelled glueagon. Working standards were prepared and unknown diluted (when required) in the same buffer supplemented with NaC1 6 g/100 ml (buffer GB). At the time of the assay, Trasylol| was added to buffer GA (buffer GA-TRAS) to reach the concentration of 5000 KIE/ml. This buffer was used to dilute the antiserum or for the blanks (see assay procedure).
Glucagon Standards
~onocomponent pork glucagon (Nero, lot MC 6770) was used as standard. Stock solutions of 50 ng/ml were stored in aliquots at --25~ Each aliquot was thawed once for the preparation of the working standard solutions (0, 50, 100, 200, 400, 600, 1000 and 2000 pg/ml) by volumetric dilution with buffer GB.
Labelled Glucagon
lalI-glucagon was purchased from the Centre National de Transfusion Sanguine, Paris. The specific activity varied from 600 to 850 ~Ci/~g. Frozen on arrival, labelled glueagon was thawed immediately prior to use and diluted with buffer GA, to provide a solution of 250 tog 181I-glueagon/ml.
Anti-Glucagon Serum
Anti-pork glueagon rabbit serum K814 (from L.G. Heding, Nero Research Institute, Copenhagen, Denmark) was used. It is considered ~s specific for pancreatic glueagon [17] .
PEG Solutions
A 23.75% (w/w) solution of PEG (providing a 12.5% final concentration in assay tubes) was freshly prepared before use by dissolving the polymer in distilled water pre-ehilled to 4 ~ C. After dissolution, continuous stirring was not required to keep homogeneity.
Reagents
Salts of analytical grade used for buffers, trichloracetic acid (TCA) and PEG 6000 were purchased from lV [ 
Blood Collection
10 ml venous blood were collected into 100 ~1 buffer GB containing 250 U heparin and 5000 KIE Trasylol| After centrifugation, the plasma was stored at --25~ The samples were thawed at room temperature, mixed and centrifuged at 4~ just prior to the assay.
Assay Procedure
During the preparation of the assay, all reagents and reaction tubes were maintained in melting ice baths. Into the glass incubation tubes (10 • 55 ram) were pipetted sequentially:
--100 ~1 of standard solutions or unknown samples; --100 ~1 of either antiserum diluted (111200) in GA-TRAS, or buffer GA-TRAS alone.
Mter 40 h of incubation at 4 ~ C, 100 ~1181I-glucagon (25 pg) were added for a second incubation of 72 h at 4 ~ C. The incubation times chosen enabled the system to reach equilibrium and provided the best slope of the standard curve. Triplicates were prepared for the standard solutions and their control containing neither unlabelled glueagon nor antiserum (blank) ; a set of tubes contained only the labelled glucagon (total radioactivity). Each unknown was assayed in duplicate with two blanks.
The standard and unknown incubation tubes were brought to the same final protein concentration by addition of 150 91 of cold human plasma, non-diluted and diluted 1/3 with buffer GB, respectively. Without delay, 0.5 ml chilled PEG (12.5% final concentration) was dispensed in all assay tubes, that were carefully shaken. This concentration of PEG was shown to ensure complete precipitation of antibody-bound hormone [8] . After 30 min incubation at 4~ the tubes were centrifuged at 4~ for 45 rain, at 1500 • g. The supernatant was decanted and the tubes left upside down on soft paper in order to complete removal of the liquid phase. Radioactivity of the precipitate was then counted for 4 rain in a well-type Automatic Gamma Analyser (Phflips).
Statistical Analysis
Statistical analysis of the results was performed according to Snedecor and Cochran [31] . The results are given as the mean =~ estimate (s) of the standard deviation (S.D.) obtained from s ---Y~ (x -[)2/(n-1)] when the number of determinations (n) is greater than 2. Use is also made of the relationship s--Y~ d2/2N], where d is the difference between the two results in a duplicate determination, and N the number of duplicate determinations performed [30] . Calculation of s provides an evaluation of the extent to which repeated measurements of the same sample agree with their mean, in a single assay (precision) or in different assays (reproducibility). This evaluation is given by the coefficient of variation C.V. = s/~, expressed as a percentage of the mean (~), or the fiducial range which estimates the limits inside which the real value is included. The fidueial range is derived from i~=k ts/gn, where IV[ is the mean of n determinations.
Whether two samples significantly differ from each other, and hence the least difference (d) required be- Statistical significance of differences between groups of samples was assessed by Student's t test.
d. Experimental Design Effect of Time and Protein Concentration Upon la~ IGlucagon Precipitation by PEG.
Series of tubes conraining buffer or plasma samples, with or without antiserum, were run as described under "Assay procedure". The effect of time was studied by allowing variable delays to elapse between completion of PEG distribution and centrifugation. Meanwhile the tubes were kept at 4 ~ C. The effect of protein concentration was studied by adding various amounts of plasma before PEG precipitation.
Effect of Proteolytie Enzyme Inhibitors upon 131I-Glucagon Degradation.
To buffer or plasma samples were added buffer GA containing the inhibitor tested, and labelled glucagon, for incubation periods identical to those of the assay. The proportion of non degraded 131I-glucagon was estimated by precipitation with TCA. Standardization of protein content in each tube was carried out immediately before addition of cold TCA (final concentration 5%, w/v). After centrifugation and decantation, the radioactivity of the precipitate was counted. Blood samples utilized for this experiment were not taken into inhibitor.
Evaluation of Precision, Sensitivity and Reproducibility of the Standard Curves. Eleven standard curves
were performed over a six months period. For comparison of the different curves together, displacement of lslI-glucagon by unlabelled gluc~gon was expressed in percentage of the precipitation recorded in the absence of unlabelled glucagon.
For each individual standard curve, the precision and quantitative sensitivity were calculated (see "Statistical Analysis") over each range of unlabelled gincagon addition. The individual values were finally pooled to provide the average C.V. =J= s and average sensitivities ~ s.
Evaluation of _Precision, Sensitivity and Reproducibility of the Assay when Applied to Plasma. C.V.
of duplicate determinations of the blank (4.28% for 600 cpm during 4 rain; n-~ 50) was not different from that of the counter (4.33% for 500 cpm during 4 rain; n ~ 25). The average blank was therefore substracted from each member of the duplicate measurement of the sample. 1 The two values found served to calculate precision and quantitative sensitivity as already described.
The reproducibility was evaluated by measuring glacagon concentration in 24 plasmas, taken at r~ndom, in two different assays. Some of these plasmas were thawed only once, whereas thawing of the others was repeated at the time of the two assays. The two glucagon concentrations found for each sample were compared by Student's t reset for 2aired data.
Recovery of Glucagon Added to Plasma. Solutions of unlabelled glucagon, with concentrations ranging from 0 to 5 ng/ml were prepared in buffer GB. To 900 ~1 of several plasmas, containing 1000 KIE Trasylol| were added 100 ~1 of the different glucagon solutions. The glucagon concentration in these samples was measured as usual.
Results and Discussion
Solubility of Free 131I-Glucagon in PEG
The solubility of la~I-glueagon in PEG concentrations ranging from 2.5 to 15% (w/w) was studied in the conditions of the assay except for the absence of antiserum. The precipitation (moan,s, n=10), expressed as the percentage of total radioactivity, increased from 5.7 J= 0.3% to 10.0 • 0.2% over the range of PEG concentrations studied.
Free glucagon, like growth hormone and parathyroid hormone [8] slightly coprecipitated with serum proteins, whereas insulin, vasopressin [8] , and angiotensin I [6] remained virtually fully soluble as PEG co~r was increased.
i For routine calculation of fhe results, the corresponding blank values were substraeted from the counts given by each standard solution and unknown sample.
Effect of Time between Addition of PEG and Centrifugation
As shown in Table 1 , delaying centrifugation for as long as 90 rain did not significantly modify the percentage of precipitated 131I-glucagon, whether the sample assayed was a plasma or a buffer. ones at the three preceding times; group b is significantly lower (p < 0.001) than the corresponding one at rain 30.
The absence of disturbance in the bound-free hormone equilibrium by PEG seems to be a characteristic of immunoassays using this polymer [6, 8] . This is in contrast with separation techniques using particulate adsorbants, which require careful control of time exposure, l~Ionaka and Fen [26] reported indeed that adsorption of free glucagon by celhflose powder, for more than 5 min, rapidly decreased the amount of antibody-bound glueagon. In our assay procedure, a 30min delay at 4~ starting at the completion of PEG distribution, was routinely adopted.
Effect of the Protein Concentration upon PEG Precipitation
Immunoglobulins are almost totally precipitated with PEG [9] and their presence in the incubation medium is required in a sufficient concentration to ensure complete precipitation of antibody-bound hormones [8] .
As illustrated in Fig. 1A , raising the volmne of plasma added to buffer samples from 0 to 100 ~l induced a two-fold increase in 181I-glueagon precipitation in the presence of antibody, ttigher volumes of plasma were much less efficient. As the volume of plasma was augmented, a slight increase of precipitated 131I-glucagon was also observed in the absence of antibody. In plasma samples (Fig. 1B) , raising the protein content above I00 V1 progressively increased l~lI-glucagon precipitation by PEG, both in the presence and the absence of antiserum.
Yet, the precipitation due to antibodies remained fairly constant, provided a plasma volume of at least 100 ~1 was present in the assay tubes, before PEG addition. Hence, the final plasma volume of all incubation tubes was brought to 150 ~l immediately before precipitation by PEG (see "Assay procedure").
Effect of Proteolytic Enzymes Inhib#ors upon ~81I-Glucagon Degradation
This series of experiments is based on the assumption that only undamaged t3tI-glucagon is precipitable by TCA. 
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Final piasma volume(FL) Table 2 shows that after incubation in buffer, 92 to 93% zalI-glucagon remained precipitable by TCA, whether the assay medium contained a proteolytic enzyme inhibitor or not. In contrast, after incubation with plasma, only 69% labelled glueagon were still precipitable. The presence of Trasylol| (500 KIE/tube) almost completely prevented lalI-glucagon degradation. Three concentrations of benzamidine tested (5, 10 and 16.5 mM) appeared to be nearly as efficient as Trasylol| alone. EACA, known to inhibit plasmin [1], showed a lower protective effect than that of the former drugs. The combination of Trasylol| (500 KIE/tube) and benzamidine (5 raM) exhibited the greatest efficiency, totally preventing glucago~ destruction by plasma.
The destruction of 131I-glucagon during incubation with human plasma, first reported by Mirsky et al. [24] , is thought to be due to plasmin. The damage of labelled glucagon during immunoassay was recognized in I963 [36] and suggested as a cause of erroneously high plasma glucagon values.
Eisentraut et al. [11] demonstrated that Trasylole, an inhibitor of kallikrein, plasmin, trypsin and chymotrypsin [33] , efficiently prevented 131I.glucagon degradation during incubation. Other agents, such as mercaptoethanol, mercurophyllin [5] , EDTA and Mg ~+ [32] , were also shown to be efficient. More recently, Ensinck et al. [12] suggested the use of benzamidine, a competitive inhibitor of plasmin, trypsin and thrombin [23] as a cheap substitute for Trasylol| The efficiency of pro-~eolytic enzymes inhibitors was studied in absence of antibodies as they protect l~lI-glucagon by themselves [35] . 0ut" results are in agreement with those of Eisentraut et al. [11] con- [5] regarding the poor effect of EACA and with those of Ensinck et al. [12] as to the use of benzamidine. Coincidence of standard curves performed in presence or absence of 5 m~ benzamidine (data not shown) ruled out a possible interference of the inhibitor with the antigen-antibody reaction. The same observation was made by Ensinck eta!.
[i2] using Unger's 30K antiserum.
Henceforth 5 ml blood samples are routinely collected into 50 ~1 buffer GB, containing heparin and benzamidine, to achieve a concentration of respectively 15 U/ml and 7.5 mM (to reach a final concentration of about 15 m3/I in plasma, assuming a 50% hematocrit value). 500 KIE Trasylol| are still added to each tube for the assay.
Precision, Sensitivity and Reproducibility of the
Standard Curves An estimate of the precision of standard curves is given in Table 3 . The average coefficient of variation remained lower than 3.2% up to 400 pg unlabelled glu- l~esults, calculated for i 1 individual standard curves, are expressed as the mean d-s (estimate of S.D.). For details in method of calculation, see section "Experimental design". cagon/ml. Differences of less than 25 pg/ml for glucagon concentrations lower than 100 pg/ml and of 33 pg/ml for concentrations between 100 and 200 pg/ml could be discriminated with 95% confidence.
Comparison of the 11 standard curves performed during successive assays was hampered by the use of different ~alI-glucagon batches. In these assays, the percentage of total ~81I-glucagon precipitated in the absence of unlabelled ghlcagon amounted to 38.i 4-9.7 (meand-s (estimate of S.D.); range: 22.6 to 52.1%). Fig. 2 demonstrates, however, a high reproducibility of the standard curves, when expressed as percentages of the radioactivity precipitated in absence of unlabelled glucagon. Furthermore, the slope of the curve was such that less than 40 pg unlabelled glucagon (400 pg/ml) were sufficient to cause a 50% fall in labelled glucagon binding by the antiserum.
Precision, Sensitivity and Reproducibility of the Assay
when Applied to Plasma Estimation of precision and sensitivity was performed on 200 plasma samples taken at random and distributed over 5 ranges of glucagon content (Table 4) . 
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Unlabeled glucagon ( pg )
Glucagon immunoassay standard curve. Each point represents the mean4-s (estimate of S.D.) of 11 different assays a M is the mean of any duplicate determination; over each range of glucagon concentration, the fiducial range of M is calculated at a level of 95~o confidence (for details see "Statistical Analysis").
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Plasmas, whose glucagon contents (ranging from 100 to 200 pg/ml) differed from about 35 pg/ml could be distinguished from each other with 95% confidence. This quantitative sensitivity was still greater for lower glucagon concentrations, and remained satisfactory for plasma glucagon contents above 300 pg/ml. The qualitative sensitivity enabled us to distinguish a glucagon concentration of 17 pg/ml from zero.
The quantitative sensitivity of the assay in plasma was similar to that of the standard curve for purified glucagon ( Table 3 Glucagon concentrations (means =ks) of the 9 plasmas thawed only once were 143.9 4-24.9 pg/ml and 146.1 =k 48.4 pg/ml in the two assays, For the 15 plasmas thawed a second time after refreezing they were 164.04-44.1 pg/ml and 159.3+36.8 pg/ml. These values were not statistically different. Thus thawing and refreezing the samples once did not seem to cause loss of glueagon immunoreaetivity in plasma collected on Trasylol| A similar observation was made by Leclereq-Meyer et al. [20] with samples taken or not on Trasylole, which were thawed 4 times. [7, 25] ; a qnalitative sensitivity of 10 pg/ ml was mentioned by Iversen [18] and by Manns [22] . For the two assays involved in the study of reprodueibility, the mean q-s of the 24 determinations were: 156.54-38.7 pg/ml (range 110 to 280) and 154.4-V 41.0 pg/ml (range 95 to 220), respectively.
500-
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When considering, for each plasma, the glucagon concentrations measured by the two assays as members of a pair, the general mean q-s was 155.4 ~ 14.8 pg/ml (for details in calculations, see "Statistical Analysis"). The C.V. of 9.5% observed was of the same importance as that expressing the precision in a single assay, for the same range of values (Table 4) .
The reproducibility of our method can hardly be compared with others since few reports were made on that particular aspect of glucagon immunoassay, validity. However, Leclercq-Meyer et al. [20] reported a C.V. of 22.7% for a single human plasma (211=k 48 pg/ ml) assayed in 17 different runs and tteding [16] mentioned a C.V. of 8.9% for a gut extract (5.4 • 0.47 ng/ml) analyzed in 25 assays. Fig. 3 shows the satisfactory recovery of exogenous glucagon added to different plasmas. The mean recoveries were 80, 104, 99, 86 and 109% respectively, for additions of 25, 50, 100, 200 and 500 pg glueagon/ ml. Only the 14% underestimation of the 200 pg addition was significant (p < 0.005). Our results are comparable with recoveries reported by Itazzard et al. [15] for glueagon additions ranging from 100 to 2500 pg/ 250 ~1 and by Leclercq-l~Ieyer et al. [20] for additions ranging from 250 to 5000 pg glucagon/ml. Fig. 4 illustrates that the experimental values fit well (p < 0.01) with the least square regression lines of measured glucagon concentrations on expected concentrations, From these results, it would seem that plasma constituents, and particularly gamma-globulins, do not interfere with glucagon measurement in our assay system. This is in contrast with previous reports [4, 37] suggesting that gamma-globulins are responsible for spuriously high plasma glucagon values measured in diluted samples, as compared with undiluted plasma. This interference could be overcome by extraction of glucagon with ethanol [16] or acetone [22] .
Recovery of Glucagon Added to Plasma
Effect of Plasma Dilution upon Apparent Glucagon Concentration
A recent report by Weir et al. [39] suggested the existence of a factor, present in variable amounts in plasma from different individuals, which interferes with the binding of ~25I-glucagon to Unger's antiserum 30K. As shown in Fig. 4 , the linear relationship observed between dilution of three plasma samples (two fasting samples and one taken during an arginine infusion) and glueagon concentration indicated that, if such factor exists, it does not seem to affect the binding of labelled glueagon to antiserum K814.
In conclusion, the use of PEG to separate free and antibody-bound hormone led to the development of a sensitive and reproducible glucagon immunoassay. Its advantages over customary techniques make it easy and reliable for routine assay of large numbers of samples.
